Association between the use of statins and periodontal status: a review
暂无分享,去创建一个
J. Nart | A. Chaparro | Jeremy R Kernitsky | D. Violant | Catherine X Andrade | David R Rosenberg | María Paz Vega
[1] A. Pradeep,et al. Subgingivally delivered 1.2% atorvastatin in the treatment of chronic periodontitis among smokers: a randomized, controlled clinical trial , 2017, Journal of investigative and clinical dentistry.
[2] S. Singhal,et al. 1.2% Rosuvastatin Versus 1.2% Atorvastatin Gel Local Drug Delivery and Redelivery in Treatment of Intrabony Defects in Chronic Periodontitis: A Randomized Placebo-Controlled Clinical Trial. , 2016, Journal of periodontology.
[3] A. Pradeep,et al. Efficacy of locally delivered 1.2% rosuvastatin gel to non-surgical treatment of patients with chronic periodontitis: a randomized, placebo-controlled clinical trial. , 2015, Journal of periodontology.
[4] J. Nart,et al. Short-term effects of 2% atorvastatin dentifrice as an adjunct to periodontal therapy: a randomized double-masked clinical trial. , 2015, Journal of periodontology.
[5] X. Zhang,et al. Simvastatin inhibits lipopolysaccharide-induced osteoclastogenesis and reduces alveolar bone loss in experimental periodontal disease. , 2014, Journal of periodontal research.
[6] Awan,et al. Simvastatin local drug delivery in smokers with chronic periodontitis: a randomized controlled clinical trial , 2013, BDJ.
[7] L. D. de Souza,et al. Atorvastatin Decreases Bone Loss, Inflammation and Oxidative Stress in Experimental Periodontitis , 2013, PloS one.
[8] R. Ribeiro,et al. Protective mechanisms of simvastatin in experimental periodontal disease. , 2013, Journal of periodontology.
[9] A. Pradeep,et al. Clinical efficacy of subgingivally delivered 1.2% atorvastatin in chronic periodontitis: a randomized controlled clinical trial. , 2013, Journal of periodontology.
[10] A. Pradeep,et al. Clinical efficacy of subgingivally delivered 1.2-mg simvastatin in the treatment of individuals with Class II furcation defects: a randomized controlled clinical trial. , 2012, Journal of periodontology.
[11] M. Sandhu,et al. A CLINICAL, RADIOLOGICAL AND IL-6 EVALUATION OF SUBGINGIVALLY DELIVERED SIMVASTATIN IN THE TREATMENT OF CHRONIC PERIODONTITIS , 2012 .
[12] P. Eke,et al. Prevalence of Periodontitis in Adults in the United States: 2009 and 2010 , 2012, Journal of dental research.
[13] S. Elavarasu,et al. Statins: A new era in local drug delivery , 2012, Journal of pharmacy & bioallied sciences.
[14] L. Bracht,et al. Topical anti‐inflammatory effect of hypocholesterolaemic drugs , 2011, The Journal of pharmacy and pharmacology.
[15] J. Gamonal,et al. Clinical attachment loss in Chilean adult population: First Chilean National Dental Examination Survey. , 2010, Journal of periodontology.
[16] A. Pradeep,et al. Clinical effect of subgingivally delivered simvastatin in the treatment of patients with chronic periodontitis: a randomized clinical trial. , 2010, Journal of periodontology.
[17] Chang Liu,et al. The Effect of Simvastatin on mRNA Expression of Transforming Growth Factor-β1, Bone Morphogenetic Protein-2 and Vascular Endothelial Growth Factor in Tooth Extraction Socket , 2009, International Journal of Oral Science.
[18] M. CarlosCalvo,et al. Efectos pleiotrópicos de las estatinas , 2008 .
[19] K. Suomalainen,et al. Statin use is associated with fewer periodontal lesions: A retrospective study , 2008, BMC oral health.
[20] Carlos León-Céspedes,et al. Efectos no hipolipemiantes de las estatinas , 2007 .
[21] A. B. Martínez,et al. Papel de la IL-6 y TNF-alfa en la enfermedad periodontal , 2006 .
[22] T. Maeda,et al. Statins and bone metabolism. , 2006, Oral diseases.
[23] BartStaels,et al. Acute Antiinflammatory Properties of Statins Involve Peroxisome Proliferator–Activated Receptor-α via Inhibition of the Protein Kinase C Signaling Pathway , 2006 .
[24] P. Gómez-Fernández. [Statins and beneficial effects]. , 2005, Medicina clinica.
[25] P. Nachtigal,et al. The changes in the endothelial expression of cell adhesion molecules and iNOS in the vessel wall after the short‐term administration of simvastatin in rabbit model of atherosclerosis , 2005, The Journal of pharmacy and pharmacology.
[26] H. Yazawa,et al. Simvastatin promotes cell metabolism, proliferation, and osteoblastic differentiation in human periodontal ligament cells. , 2005, Journal of periodontology.
[27] T. Maeda,et al. Statins augment vascular endothelial growth factor expression in osteoblastic cells via inhibition of protein prenylation. , 2003, Endocrinology.
[28] A. M. Lefer,et al. A new HMG‐CoA reductase inhibitor, rosuvastatin, exerts anti‐inflammatory effects on the microvascular endothelium: the role of mevalonic acid , 2001, British journal of pharmacology.
[29] T. Komori,et al. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. , 2000, Endocrine reviews.
[30] Ross R. Muth,et al. Biodegradable polymers for use in surgery—polyglycolic/poly(actic acid) homo- and copolymers: 1 , 1979 .
[31] D. Erdogan,et al. Assessment of vascular endothelial growth factor and matrix metalloproteinase-9 in the periodontium of rats treated with atorvastatin. , 2014, Journal of periodontology.
[32] A. Pradeep,et al. Efficacy of subgingivally delivered simvastatin in the treatment of patients with type 2 diabetes and chronic periodontitis: a randomized double-masked controlled clinical trial. , 2013, Journal of periodontology.